Cargando…

Influence of rosuvastatin dose on total fatty acids and free fatty acids in plasma: Correlations with lipids involved in cholesterol homeostasis

This study investigates for the first time the influence of four doses of rosuvastatin on total fatty acids (TFA) and free fatty acids (FFA) in human plasma and correlates their changes in concentration with changes in the concentration of other lipids involved in cholesterol homeostasis. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciucanu, Cristian I., Olariu, Sonia, Vlad, Daliborca C., Dumitraşcu, Victor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710209/
https://www.ncbi.nlm.nih.gov/pubmed/33235104
http://dx.doi.org/10.1097/MD.0000000000023356
_version_ 1783617899785617408
author Ciucanu, Cristian I.
Olariu, Sonia
Vlad, Daliborca C.
Dumitraşcu, Victor
author_facet Ciucanu, Cristian I.
Olariu, Sonia
Vlad, Daliborca C.
Dumitraşcu, Victor
author_sort Ciucanu, Cristian I.
collection PubMed
description This study investigates for the first time the influence of four doses of rosuvastatin on total fatty acids (TFA) and free fatty acids (FFA) in human plasma and correlates their changes in concentration with changes in the concentration of other lipids involved in cholesterol homeostasis. This study was a placebo-controlled, randomized, double-blind, crossover experiment. The study used a single group of 16 men and consisted of 5 treatment periods lasting 4 weeks each with placebo and 4 doses of rosuvastatin (5, 10, 20, and 40 mg). Each subject changed 5 medical treatments and received in each new treatment different tablets of rosuvastatin or placebo compared to those taken in previous treatments, in a random order. Between treatment periods there was a wash-out period of 2 weeks, without treatment. Changes in TFA and FFA were significant compared to placebo and between different doses of rosuvastatin. We found a continuous logarithmic decrease in levels of TFA, FFA, low-density lipoprotein (LDL)-cholesterol, total cholesterol, triglycerides, phospholipids, and apolipoprotein B-100, and a continuous increase in levels of high-density lipoprotein (HDL)-cholesterol and apolipoprotein A-1 by increases the dose of rosuvastatin. Analysis of the correlation of TFA and FFA with the main lipids and lipoproteins in cholesterol homeostasis indicated a linear regression with high correlation coefficients and all P-values were less than .05 level. The concentrations of TFA and FFA are significantly influenced by the dose of rosuvastatin. They are strongly correlated with those of other lipids and lipoproteins involved in cholesterol homeostasis. The mechanisms of cholesterol homeostasis regulation are involved in changing the concentrations of TFA and FFA.
format Online
Article
Text
id pubmed-7710209
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-77102092020-12-03 Influence of rosuvastatin dose on total fatty acids and free fatty acids in plasma: Correlations with lipids involved in cholesterol homeostasis Ciucanu, Cristian I. Olariu, Sonia Vlad, Daliborca C. Dumitraşcu, Victor Medicine (Baltimore) 4200 This study investigates for the first time the influence of four doses of rosuvastatin on total fatty acids (TFA) and free fatty acids (FFA) in human plasma and correlates their changes in concentration with changes in the concentration of other lipids involved in cholesterol homeostasis. This study was a placebo-controlled, randomized, double-blind, crossover experiment. The study used a single group of 16 men and consisted of 5 treatment periods lasting 4 weeks each with placebo and 4 doses of rosuvastatin (5, 10, 20, and 40 mg). Each subject changed 5 medical treatments and received in each new treatment different tablets of rosuvastatin or placebo compared to those taken in previous treatments, in a random order. Between treatment periods there was a wash-out period of 2 weeks, without treatment. Changes in TFA and FFA were significant compared to placebo and between different doses of rosuvastatin. We found a continuous logarithmic decrease in levels of TFA, FFA, low-density lipoprotein (LDL)-cholesterol, total cholesterol, triglycerides, phospholipids, and apolipoprotein B-100, and a continuous increase in levels of high-density lipoprotein (HDL)-cholesterol and apolipoprotein A-1 by increases the dose of rosuvastatin. Analysis of the correlation of TFA and FFA with the main lipids and lipoproteins in cholesterol homeostasis indicated a linear regression with high correlation coefficients and all P-values were less than .05 level. The concentrations of TFA and FFA are significantly influenced by the dose of rosuvastatin. They are strongly correlated with those of other lipids and lipoproteins involved in cholesterol homeostasis. The mechanisms of cholesterol homeostasis regulation are involved in changing the concentrations of TFA and FFA. Lippincott Williams & Wilkins 2020-11-25 /pmc/articles/PMC7710209/ /pubmed/33235104 http://dx.doi.org/10.1097/MD.0000000000023356 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle 4200
Ciucanu, Cristian I.
Olariu, Sonia
Vlad, Daliborca C.
Dumitraşcu, Victor
Influence of rosuvastatin dose on total fatty acids and free fatty acids in plasma: Correlations with lipids involved in cholesterol homeostasis
title Influence of rosuvastatin dose on total fatty acids and free fatty acids in plasma: Correlations with lipids involved in cholesterol homeostasis
title_full Influence of rosuvastatin dose on total fatty acids and free fatty acids in plasma: Correlations with lipids involved in cholesterol homeostasis
title_fullStr Influence of rosuvastatin dose on total fatty acids and free fatty acids in plasma: Correlations with lipids involved in cholesterol homeostasis
title_full_unstemmed Influence of rosuvastatin dose on total fatty acids and free fatty acids in plasma: Correlations with lipids involved in cholesterol homeostasis
title_short Influence of rosuvastatin dose on total fatty acids and free fatty acids in plasma: Correlations with lipids involved in cholesterol homeostasis
title_sort influence of rosuvastatin dose on total fatty acids and free fatty acids in plasma: correlations with lipids involved in cholesterol homeostasis
topic 4200
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710209/
https://www.ncbi.nlm.nih.gov/pubmed/33235104
http://dx.doi.org/10.1097/MD.0000000000023356
work_keys_str_mv AT ciucanucristiani influenceofrosuvastatindoseontotalfattyacidsandfreefattyacidsinplasmacorrelationswithlipidsinvolvedincholesterolhomeostasis
AT olariusonia influenceofrosuvastatindoseontotalfattyacidsandfreefattyacidsinplasmacorrelationswithlipidsinvolvedincholesterolhomeostasis
AT vladdaliborcac influenceofrosuvastatindoseontotalfattyacidsandfreefattyacidsinplasmacorrelationswithlipidsinvolvedincholesterolhomeostasis
AT dumitrascuvictor influenceofrosuvastatindoseontotalfattyacidsandfreefattyacidsinplasmacorrelationswithlipidsinvolvedincholesterolhomeostasis